CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

Compass’ psilocybin shows six-month durability in Phase III trial

Phase 3
Related Companies

Read the original article

Published by Clinical Trials Arena on July 7, 2026 2:31 PM

Read Original